Nienaber C A, von Kodolitsch Y
Abteilung für Kardiologie und Angiologie des Universitätskrankenhauses Hamburg-Eppendorf.
Herz. 1992 Dec;17(6):398-416.
The acute dissection of the thoracic aorta is a potentially lethal event with a death rate of 1 to 2% per hour urging for undelayed diagnosis and adequate treatment. First, this paper highlights both the demographic characteristics and the classification according to anatomical and prognostic criteria, i.e. class I to III according to DeBakey and type A and B according to Daily (or Stanford). Moreover, the etiology of aortic dissection is explained, including factors such as degenerative changes of the aortic media layer, chronic trauma from hypertension, primary connective tissue disease and acute deceleration trauma. Second, the clinical criteria of acute (within 14 days of the index event) and chronic dissection (> 14 days) is discussed with respect to the current literature. The dominant part of this paper represents a meta-analytic approach comprising all available literature sources with respect to emerging changes in the prognosis of thoracic aortic dissection over 40 years as a function of either the type, the anatomic location, the acuity or the impact of medical or surgical treatment of this disorder. The meta-analysis revealed that in acute and chronic type A dissection medical treatment alone failed to lead to a significant improvement of 30 day-mortality rate (Tables 1 and 2, Figure 1). However, with surgical interventions the 30 day-mortality rate was continuously lowered from 60% to 10% within the past 30 years. A similar evolution was observed for the chronic type A dissection (Tables 3 and 4, Figure 2). Furthermore, the meta-analysis revealed that the acute type B dissection benefits from medical treatment, especially antihypertensive medication since the 30 day-mortality of 40% in 1960 decreased to less than 10% at present with monitoring and effective medication (Tables 1 and 2, Figure 3). In case of chronic type B dissection the literature survey revealed mortality numbers fluctuating between 2% and 20% without a clearcut beneficial effect of medical therapy throughout these years, though possibly revealing some advantage over surgical treatment. Thus, both for the acute and chronic type B dissection the antihypertensive therapy is considered treatment of first choice, whereas surgical interventions may be necessary for complicated and progressive cases. In summary, compared to the natural course of thoracic aortic dissection with only 10% survival-rate after one year of onset (Table 9, Figure 5), any effective mode of treatment may significantly lower the high spontaneous death rate.(ABSTRACT TRUNCATED AT 400 WORDS)
胸主动脉急性夹层是一种潜在的致死性疾病,每小时死亡率为1%至2%,因此需要及时诊断和适当治疗。首先,本文重点介绍了其人口统计学特征以及根据解剖学和预后标准进行的分类,即根据DeBakey分类为I至III类,根据Daily(或Stanford)分类为A型和B型。此外,还解释了主动脉夹层的病因,包括主动脉中层退变、高血压引起的慢性创伤、原发性结缔组织病和急性减速创伤等因素。其次,结合当前文献讨论了急性(指数事件发生后14天内)和慢性夹层(>14天)的临床标准。本文的主要部分采用了荟萃分析方法,涵盖了所有可用文献来源,探讨了40年来胸主动脉夹层预后的新变化,这些变化是类型、解剖位置、急性程度或该疾病药物或手术治疗影响的函数。荟萃分析显示,在急性和慢性A型夹层中,单纯药物治疗未能显著提高30天死亡率(表1和表2,图1)。然而,通过手术干预,在过去30年中,30天死亡率从60%持续降至10%。慢性A型夹层也观察到了类似的演变(表3和表4,图2)。此外,荟萃分析表明,急性B型夹层受益于药物治疗,尤其是抗高血压药物,因为1960年40%的30天死亡率目前通过监测和有效药物治疗降至不到10%(表1和表2,图3)。对于慢性B型夹层,文献调查显示这些年死亡率在2%至20%之间波动,药物治疗没有明显的有益效果,尽管可能显示出比手术治疗有一些优势。因此,对于急性和慢性B型夹层,抗高血压治疗均被视为首选治疗方法,而对于复杂和进展性病例可能需要手术干预。总之,与胸主动脉夹层自然病程相比,发病一年后生存率仅为10%(表9,图5),任何有效的治疗方式都可能显著降低高自发死亡率。(摘要截取自400字)